Swiss startup Limula raises $6.8M for cell therapy automation
Longevity Technology - 22-May-2024Company is aiming to increase accessibility and affordability
Join the club for FREE to access the whole archive and other member benefits.
Personalised cancer treatments
Limula provides an innovative solution for the production of the most personalised cancer treatments on demand and at scale. Their product is a unique proprietary platform can perform multiple steps of cell therapy manufacturing in a single device, using end-to-end automation and integrated process analytics.
Visit website: https://limula.ch/
Details last updated 26-May-2024
Company is aiming to increase accessibility and affordability